Across TCGA pan-cancer cohorts, CA13 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CA13 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher CA13 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CA13 expression acts as an unfavorable survival marker.

ESCA and PRAD are the cancer types where CA13 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	All	0.022	0.701	<.001	12	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CA13 tumor-vs-normal RNA expression · all CA13 data types